Clinical Trial Update: Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

This clinical-trial update reports a Phase 2 study evaluating oxaliplatin and docetaxel for recurrent or metastatic head and neck cancer. The trial status is te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Minneapolis Veterans Affairs Medical Center | Conditions: Neoplasms, Head and Neck Neoplasms | Phase 2 | Status: TERMINATED